Johnson & Johnson (NYSE:JNJ) received FDA approval for DARZALEX FASPRO in combination with D-VRd. The regimen is approved for ...

In the last six months Pfizer’s stock (NYSE: PFE) has underperformed Merck (NYSE: MRK) and J&J (NYSE: JNJ) primarily due to ...

Johnson & Johnson (JNJ) stock gains as Morgan Stanley upgrades the company to Overweight, lifting the price target to $262, ...

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Johnson & Johnson (NYSE:JNJ) is among the most profitable healthcare stocks to buy. On January 22, TD Cowen lifted the price target on Johnson & Johnson (NYSE:JNJ) to $250, up from $222, and ...

Johnson & Johnson’s post-Kenvue shift boosts growth and free cash flow, with an elite balance sheet but mixed revisions. Learn more about JNJ stock here.

Johnson & Johnson (NYSE:JNJ) is one of the 10 Hottest Stocks to Buy in 2026. On January 28, TheFly reported that Morgan ...

Johnson & Johnson (NYSE:JNJ) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. Johnson & Johnson ...

Johnson & Johnson is a picture of stability.

After a strong performance in 2025, Johnson & Johnson is starting the new year right.

The current macro investing climate is one in which investors have plenty to consider. On the one hand, growth stocks ...